BioSpace News Archive

OncoSec Medical Incorporated announced it intends to effect a 1-for-22 reverse split of its issued and outstanding common stock.

Sentynl Therapeutics, Inc. (“Sentynl”) a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare disease, joins the global Menkes disease community including the Menkes Foundation (“Menkes Foundation”) in recognizing the month of November as Menkes Disease Awareness Month.

According to Vision Research Reports, the global medical enzyme technology market size was valued at US$ 4.37 billion in 2021 and it is expected to hit around US$ 7.38 billion by 2030. It is projected to expand at a CAGR of 6% during the forecast period 2022-2030.

The Microbial fermentation technology involves the usage of microorganisms for producing valuable products that have immense medical and industrial applications in biotechnology.

The global mycoplasma testing market size was valued at USD 761.51 million in 2021 and it is predicted to surpass around USD 2.32 billion by 2030 with a CAGR of 13.18% from 2022 to 2030.

According to the Vision Research Reports, the global neuropathic pain therapeutics market size surpassed US$ 6.58 billion in 2021 and to reach US$ 10.21 billion by 2030 with a CAGR of 5% from 2022 to 2030.

The global Ophthalmic Drugs market size is expected to be worth around US$ 70.5 billion by 2030, according to a new report by Vision Research Reports.

The global MiRNA Sequencing And Assay market size is expected to be worth around US$ 600.8 Mn by 2030, according to a new report by Vision Research Reports

The oncolytic virus immunotherapy market reached value at US$ 108 Million in 2020 and predicted to hit US$ 2.4 billion by 2030 with expanding CAGR of 32% from 2021 to 2030.

According to Vision Research Reports, the global organoids market size was valued over US$ 2.19 billion in 2021 and is predicted to reach over US$ 12.7 billion by 2030, at a CAGR of 21.58 % from 2022 to 2030.